Matinas BioPharma

Biotechnology ResearchNew Jersey, United States11-50 Employees

Matinas BioPharma is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules through its lipid nanocrystal platform. The company pursues an internal product portfolio and collaborates with leading pharmaceutical firms to develop formulations that leverage the distinctive properties of its technology. Preclinical and clinical data have indicated this approach can address key challenges in achieving safe and effective intracellular delivery for a range of modalities, including mRNA, DNA plasmids, antisense oligonucleotides, and vaccines. The platform emphasizes formulation flexibility and routes of administration, including the potential for oral delivery, which could offer advantages over existing delivery methods. Based in Bedminster, New Jersey, Matinas engages with major pharmaceutical companies to advance these formulations, and its 2025 governance updates include additions to its independent board.

Sign up for free to view info

Email Format Employee directory